HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kentarou Kudou Selected Research

Kentarou Kudou Research Topics

Disease

5Menorrhagia
10/2021 - 01/2019
3Leiomyoma (Uterine Fibroids)
10/2021 - 01/2019
3Pain (Aches)
01/2021 - 11/2019
3Metrorrhagia (Spotting)
01/2021 - 11/2019
3Hypertriglyceridemia
12/2015 - 05/2013
2Pelvic Pain
01/2021 - 01/2021
2Endometriosis
01/2021 - 01/2021
1Duodenal Ulcer (Curling's Ulcer)
07/2022
1Gastroparesis
01/2022
1Menstruation Disturbances
01/2021
1Hyperhidrosis
11/2019
1Respiratory Tract Infections (Respiratory Tract Infection)
11/2019
1Myoma
01/2019
1Hemorrhage
01/2019
1Heartburn (Pyrosis)
04/2018
1Esophagitis
04/2018
1Prostatic Neoplasms (Prostate Cancer)
12/2015
1Cardiovascular Diseases (Cardiovascular Disease)
05/2013
1Dyslipidemias (Dyslipidemia)
05/2013

Drug/Important Bio-Agent (IBA)

5relugolixIBA
10/2021 - 01/2019
4Gonadotropin-Releasing Hormone (GnRH)FDA Link
10/2021 - 01/2019
4LHRH Receptors (Gonadotropin-Releasing Hormone Receptor)IBA
10/2021 - 11/2019
4Leuprolide (Lupron)FDA LinkGeneric
01/2021 - 12/2015
3TAK-085IBA
12/2015 - 05/2013
2Lansoprazole (Prevacid)FDA LinkGeneric
07/2022 - 04/2018
2Pharmaceutical PreparationsIBA
07/2022 - 11/2019
21- (5- (2- fluorophenyl)- 1- (pyridin- 3- ylsulfonyl)- 1H- pyrrol- 3- yl)- N- methylmethanamineIBA
07/2022 - 04/2018
2Acetates (Acetic Acid Esters)FDA Link
01/2019 - 12/2015
2Eicosapentaenoic AcidIBA
12/2015 - 05/2013
24,7,10,13,16,19-docosahexaenoic acid ethyl esterIBA
11/2013 - 05/2013
2eicosapentaenoic acid ethyl esterIBA
11/2013 - 05/2013
2Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
11/2013 - 05/2013
2Triglycerides (Triacylglycerol)IBA
11/2013 - 05/2013
1trazpirobenIBA
01/2022
1Dopamine (Intropin)FDA LinkGeneric
01/2022
1Hemoglobins (Hemoglobin)IBA
01/2019
1AcidsIBA
04/2018
1LDL CholesterolIBA
12/2015
1LDL Lipoproteins (beta Lipoproteins)IBA
12/2015
1EstersIBA
12/2015
1ApolipoproteinsIBA
12/2015
1oxidized low density lipoproteinIBA
12/2015
1polyacrylamideIBA
12/2015
1LipidsIBA
11/2013

Therapy/Procedure

2Therapeutics
01/2022 - 04/2018
1Oral Administration
01/2021
1Injections
01/2019
1Aftercare (After-Treatment)
01/2019